Bank of New York Mellon’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-917,939
| Closed | -$78.1M | – | 4295 |
|
|
2020
Q3 | $78.1M | Buy |
917,939
+83,955
| +10% | +$4.25M | 0.02% | 683 |
|
|
2020
Q2 | $29.6M | Sell |
833,984
-39,164
| -4% | -$1.14M | 0.01% | 1188 |
|
|
2020
Q1 | $11.8M | Buy |
873,148
+22,040
| +3% | +$371K | ﹤0.01% | 1608 |
|
|
2019
Q4 | $18M | Buy |
851,108
+20,588
| +2% | +$363K | ﹤0.01% | 1632 |
|
|
2019
Q3 | $11M | Sell |
830,520
-13,034
| -2% | -$192K | ﹤0.01% | 1869 |
|
|
2019
Q2 | $11.7M | Buy |
843,554
+101,534
| +14% | +$1.53M | ﹤0.01% | 1875 |
|
|
2019
Q1 | $14.3M | Buy |
742,020
+39,811
| +6% | +$642K | ﹤0.01% | 1771 |
|
|
2018
Q4 | $10M | Sell |
702,209
-747
| -0.1% | -$14.8K | ﹤0.01% | 1894 |
|
|
2018
Q3 | $14.6M | Sell |
702,956
-2,774
| -0.4% | -$65.7K | ﹤0.01% | 1824 |
|
|
2018
Q2 | $16.7M | Buy |
705,730
+104,742
| +17% | +$2.11M | ﹤0.01% | 1713 |
|
|
2018
Q1 | $8.78M | Buy |
600,988
+23,529
| +4% | +$384K | ﹤0.01% | 2045 |
|
|
2017
Q4 | $9.33M | Sell |
577,459
-103,960
| -15% | -$1.23M | ﹤0.01% | 2025 |
|
|
2017
Q3 | $9.53M | Buy |
681,419
+53,284
| +8% | +$531K | ﹤0.01% | 2010 |
|
|
2017
Q2 | $5.55M | Buy |
628,135
+163,920
| +35% | +$1.15M | ﹤0.01% | 2283 |
|
|
2017
Q1 | $3M | Buy |
464,215
+23,518
| +5% | +$119K | ﹤0.01% | 2609 |
|
|
2016
Q4 | $1.62M | Buy |
440,697
+32,033
| +8% | +$94.8K | ﹤0.01% | 2979 |
|
|
2016
Q3 | $1.33M | Sell |
408,664
-22,842
| -5% | -$63.9K | ﹤0.01% | 3020 |
|
|
2016
Q2 | $1M | Buy |
431,506
+10,105
| +2% | +$33.8K | ﹤0.01% | 3130 |
|
|
2016
Q1 | $1.05M | Sell |
421,401
-24,096
| -5% | -$54.2K | ﹤0.01% | 3025 |
|
|
2015
Q4 | $1.37M | Buy |
445,497
+16,198
| +4% | +$45.2K | ﹤0.01% | 2955 |
|
|
2015
Q3 | $739K | Sell |
429,299
-132,576
| -24% | -$338K | ﹤0.01% | 3368 |
|
|
2015
Q2 | $2.28M | Buy |
561,875
+35,018
| +7% | +$143K | ﹤0.01% | 2820 |
|
|
2015
Q1 | $2.02M | Buy |
526,857
+80,047
| +18% | +$348K | ﹤0.01% | 2857 |
|
|
2014
Q4 | $2.15M | Buy |
446,810
+17,192
| +4% | +$68K | ﹤0.01% | 2834 |
|
|
2014
Q3 | $1.6M | Buy |
429,618
+42,833
| +11% | +$145K | ﹤0.01% | 3028 |
|
|
2014
Q2 | $1.41M | Buy |
386,785
+15,628
| +4% | +$57.4K | ﹤0.01% | 3114 |
|
|
2014
Q1 | $1.56M | Sell |
371,157
-1,758
| -0.5% | -$8.72K | ﹤0.01% | 3041 |
|
|
2013
Q4 | $1.72M | Sell |
372,915
-14,815
| -4% | -$66K | ﹤0.01% | 2975 |
|
|
2013
Q3 | $2.4M | Sell |
387,730
-6,884
| -2% | -$39.6K | ﹤0.01% | 2727 |
|
|
2013
Q2 | $2.15M | Buy |
+394,614
| New | +$1.3M | ﹤0.01% | 2745 |
|
Bank of New York Mellon's IMMU Position: Q4 2020 in Review
Bank of New York Mellon sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 917,939 shares — an estimated $78.1M sold.
Bank of New York Mellon first reported a position in IMMU in Q2 2013 and held it in 30 quarters. The position peaked at $78.1M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Bank of New York Mellon reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Bank of New York Mellon sold 917,939 Immunomedics Inc shares in Q4 2020, an estimated $78.1M.
- Bank of New York Mellon first reported a position in Immunomedics Inc in Q2 2013 and held it in 30 quarters.
- Bank of New York Mellon's Immunomedics Inc position peaked at $78.1M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Bank of New York Mellon's 13F filing for Q4 2020, filed 9 Feb 2021.